Boeing stock falls 9% as 737 Max ramp-up slips to late 2027

2 min read
Boeing stock falls 9% as 737 Max ramp-up slips to late 2027
PrimeXBT Editorial Team
Reviewed by PrimeXBT

Topics in article

Boeing does not expect to significantly ramp up 737 Max output until the second half of 2027, and its stock fell about 9% during the earnings call. The company narrowed its third-quarter loss on defense growth, but the adjusted loss per share came in wider than analysts expected.

Boeing targets 52 737 Max planes a month in the second half of 2027, CEO Kelly Ortberg said on Tuesday's quarterly earnings call. The company grapples with a slower-than-expected pace of wing production. Boeing has been manufacturing about 47 of the planes a month.

The stock was down about 9% during the call. Ortberg told CNBC's Phil LeBeau: "I know everybody wants us to go faster but we're going to do it right,"

Defense sales narrow the quarterly loss

For the three months ended Sept. 30, Boeing reported a net loss of $116 million, or 26 cents a share. A year earlier, the loss was $5.34 billion, or $7.14 per share. Adjusted for one-time items, the loss per share was 34 cents, against a loss of 21 cents expected by analysts, according to LSEG consensus estimates.

Revenue climbed 4% to $24.19 billion, above the $23.84 billion expected. Defense unit revenue jumped 15% to $7.94 billion. Free cash flow rose to $464 million from $238 million in the third quarter of 2025.

Commercial unit posts a negative margin

Revenue in the commercial aircraft business fell 3% to $10.72 billion. The unit had a negative operating margin of 6.5%, which Boeing attributed to a less favorable delivery mix, higher projected costs tied to future production rate adjustments and higher estimated supply chain costs. Boeing delivered 161 commercial airplanes, one more than a year earlier.

The Federal Aviation Administration last week signed off on the 737 Max 10, following approval of the 737 Max 7 in August, which marked the final certifications for the aircraft line.

Source: CNBC

Trading involves risk.

Most traded markets

XAU / USD
+1.09% 4,060.83
CRUDE
-1.22% 101.428
BTC / USD
+0.24% 80,625.6
EUR / USD
-0.3% 1.11395
USTEC
+1.21% 29,644.36
NFLX
-1.89% 62.45
View all markets

Author

PrimeXBT
Our Editorial Team consists of leading experts with a proven record in the fields of trading, cryptocurrencies, blockchain and finance. We thoroughly research the sources of information in order to provide readers with quality content that serves edu...
Read author’s articles
Alert Triangle Risk Disclaimer
Disclaimer: Some past publications may be outdated. We recommend following our news to stay up to date with the latest information. For any questions, feel free to contact our support team via the chat below.
The content provided here is for informational purposes only. It is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results.
The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money.
The Company does not accept clients from the Restricted Jurisdictions as indicated in our website/ T&C. Some services or products may not be available in your jurisdiction.
The applicable legal entity and its respective products and services depend on the client’s country of residence and the entity with which the client has established a contractual relationship during registration.

Today in markets

Browse Stock News

Register Now

Trading involves risk

Get started in minutes

Our clients love how fast and simple our sign-up is. It takes just a few minutes to get started!

Get Started Get Started
Get started in minutes

Need Help?

Risk Warning:
Trading in leveraged products carries a high level of risk and may not be suitable for all investors.